Advertisement
Skip to Content

Tilray Brands Inc TLRY Stock Quote

| Rating as of

NASDAQ: TLRY

Last close prices updated as of Jun 08, 2023, 4:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 1.67
  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Investment Style Small Value
  • Day Range 1.65  –  1.73
  • Year Range 1.63  –  5.12
  • Market Cap 1.0964 Bil
  • Volume / Avg 23.6 Mil /  12.9 Mil
  • Price / Sales 1.67
  • Price / Book 0.33
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis TLRY

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

Tilray: Shares Plunge on Dilutive Convertible Notes Offering, but Magnitude Is an Overreaction

Unlock Our Full Analysis With Morningstar Investor

Key Statistics TLRY

Company Profile TLRY

Business Description

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.

Contact
265 Talbot Street West
Leamington, ON, N8H 5L4, CAN
Industry Drug Manufacturers - Specialty & Generic
Employees 1,700

Related Articles TLRY

Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of TLRY’s competitive advantage.

Tilray Brands Inc

XNAS: TLRY

Aurora Cannabis Inc

XTSE: ACB

Canopy Growth Corp

XTSE: WEED

Cronos Group Inc

XTSE: CRON
Price
1.670.690.922.25
Currency
USDCADCADCAD
Change
−$0.06 (3.47%) −$0.01 (1.43%) −$0.06 (6.12%) −$0.05 (2.17%)
Market Cap
1.10 Bil235.28 Mil479.32 Mil856.84 Mil
Industry
Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Healthcare
Healthcare
Healthcare

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Tilray Brands Inc Stock

No. TLRY does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

TLRY’s market cap is 1.10 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

TLRY’s stock style is Small Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

TLRY’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare TLRY’s historical performance against its industry peers and the overall market.